Patents Assigned to Kriya Therapeutics, Inc.
  • Viral vector constructs for delivery of nucleic acids encoding cytokines and uses thereof for treating cancer
    Patent number: 12071633
    Abstract: The present disclosure provides the gene therapy compositions comprising vectors (e.g., viral vectors) suitable for delivery of nucleic acids encoding immunomodulatory proteins or functional fragments thereof, and methods of using the same. Certain aspects of the disclosure are directed to an adeno-viral vector (AAV) delivery of nucleic acids encoding two or more immunomodulatory proteins or functional fragments thereof to a tumor.
    Type: Grant
    Filed: October 13, 2021
    Date of Patent: August 27, 2024
    Assignee: Kriya Therapeutics, Inc.
    Inventors: Brian Furmanski, Nachiketa Gupta, Bruce Schnepp, Michele Stone